Analyst Cautions Investors On Overreacting To ‘Early-Stage’ Pfizer/Seagen Discussions
In a news article by the Wall Street Journal, Pfizer Inc (NYSE:PFE) is reportedly in early-stage talks to acquire Seagen Inc (NASDAQ:SGEN) for…
Why Reata Pharmaceuticals Shares Are Falling Monday?
According to various reports, the FDA's neuroscience expert Billy Dunn is leaving the agency after more than 15 years, effective immediately.
Shionogi’s COVID-19 Pill, Based On Similar Action Like Pfizer’s, Sees Around $2B In Annual Sales
Japanese pharmaceutical company Shionogi & Co Ltd's CEO believes its COVID-19, Xocova, pill can generate $2 billion in annual sales if it secures FDA approval.
The company expects U.S. approval by late 2024.
TransCode Therapeutics Gets Orphan Designation Status On Dextran-Coated, Nanoparticle-Conjugated Stabilized Synthetic Antisense Oligonucleotide Targeting miR-10b For The Treatment Of Pancreatic Cancer
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=926622
Jaguar Health Subsidiary Napo Pharmaceuticals Inc. Gets FDA Orphan Drug Designation For Crofelemer For Treatment Of Microvillus Inclusion Disease
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=897722
Biophytis Seeks Early Access Authorization For Its COVID-19 Treatment In France
Biophytis SA (NASDAQ:BPTS) has begun the early access application process in France for Sarconeos (BIO101) for the treatment of severe COVID-19.…
Hyperfine Has Been Granted FDA 510k Clearance For The Swoop Portable MR Imaging System
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K230208
Lucira Health is Soaring Monday: Here Are The Details
Lucira Health Inc (NASDAQ: LHDX) shares are soaring on Monday after the company announced U.S.
Lucy Scientific Discovery Announces First Commercial Sale Of Psilocybin Following Initial Delivery Of DMT And 5-MeO-DMT To Hadassah BrainLabs
Lucy Scientific Discovery Inc. ("Lucy" or the "Company") (NASDAQ:LSDI), an early-stage manufacturing company that is focused on becoming the premier research, development, and manufacturing
SciSparc Signs Agreement For The Supply Of CBD-Rich Cannabis Oil For Its Clinical Trial On Children With Autism Spectrum Disorder
The cannabis oil will be used as a part of the Company's proprietary SCI-210 treatment combination of CBD and CannAmide™